CAS 121250-47-3: Conjugated linoleic acid

Conjugated linoleic acid is a conjugated fatty acid, consisting of a linoleic acid molecule with two or three double bonds. It has been shown to have inhibitory properties against pathogens such as Escherichia coli and Salmonella enterica. Conjugated linoleic acid also has anti-inflammatory effects on bowel disease and the energy metabolism in adipose tissue. It is thought that the action of conjugated linoleic acid on these processes is due to its ability to bind to enzymes involved in metabolic pathways. The following is an example of product description for eCommerce: Rifapentine is an anti-tuberculosis drug that belongs to the class of rifamycins. It is the most active of the rifamycins for the treatment of tuberculosis. Rifapentine inhibits bacterial growth by binding to DNA-dependent RNA polymerase, thereby preventing transcription and replication. The high frequency of human activity

Conjugated linoleic acid is found in ruminant meat and dairy, made via rumen bio-hydrogenation, mainly as 9cis, 11trans isomer.

Conjugated linoleic acid (CLA) is a fatty acid found in beef and dairy products. It is a conjugated form of linoleic acid, which means it has two or more double bonds in its chemical structure. CLA may help to regulate energy metabolism by inhibiting the activity of enzymes involved in fat and carbohydrate metabolism. CLA has also been shown to have inhibitory properties against polymerase chain reaction (PCR), an enzyme that copies DNA during cell division. CLA has also been shown to reduce the symptoms of bowel disease, including reducing inflammation and improving insulin sensitivity. CLA may suppress body weight gain and fat accumulation in humans, as well as reduce the development of type 2 diabetes mellitus. In addition, CLA may be effective against infectious diseases such as tuberculosis and HIV/AIDS because it can lower levels of pro-inflammatory cytokines like tumor necrosis factor-α (TNF-α)